Targeted next-generation sequencing revealed distinct clinicopathologic and molecular features of VCL-ALK RCC: A unique case from an older patient without clinical evidence of sickle cell trait.

MLA

Wang, Xiao-tong, et al. “Targeted Next-Generation Sequencing Revealed Distinct Clinicopathologic and Molecular Features of VCL-ALK RCC: A Unique Case from an Older Patient without Clinical Evidence of Sickle Cell Trait.” Pathology - Research & Practice, vol. 215, no. 11, Nov. 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.prp.2019.152651.

APA

Wang, X., Fang, R., Ye, S., Zhang, R., Li, R., Wang, X., Ji, R., Lu, Z., Ma, H., Zhou, X., Xia, Q., & Rao, Q. (2019). Targeted next-generation sequencing revealed distinct clinicopathologic and molecular features of VCL-ALK RCC: A unique case from an older patient without clinical evidence of sickle cell trait. Pathology - Research & Practice, 215(11), N.PAG. https://doi.org/10.1016/j.prp.2019.152651

Chicago

Wang, Xiao-tong, Ru Fang, Sheng-bing Ye, Ru-song Zhang, Rui Li, Xuan Wang, Rong-hao Ji, et al. 2019. “Targeted Next-Generation Sequencing Revealed Distinct Clinicopathologic and Molecular Features of VCL-ALK RCC: A Unique Case from an Older Patient without Clinical Evidence of Sickle Cell Trait.” Pathology - Research & Practice 215 (11): N.PAG. doi:10.1016/j.prp.2019.152651.